

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 6.41404480 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.83931570 |
| 3 | negative regulation of interleukin-12 production (GO:0032695) | 5.74396279 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 5.74288124 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.74288124 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.48337515 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.48337515 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.37789803 |
| 9 | negative regulation of cell killing (GO:0031342) | 5.37789803 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 5.27452480 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.22022902 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 5.14243899 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 5.10642583 |
| 14 | complement activation, alternative pathway (GO:0006957) | 5.00188507 |
| 15 | plasma lipoprotein particle clearance (GO:0034381) | 4.98386214 |
| 16 | cellular extravasation (GO:0045123) | 4.96746225 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 4.92061162 |
| 18 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.87985529 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.84207371 |
| 20 | protein carboxylation (GO:0018214) | 4.84207371 |
| 21 | detection of other organism (GO:0098543) | 4.82722054 |
| 22 | detection of molecule of bacterial origin (GO:0032490) | 4.81776507 |
| 23 | bile acid biosynthetic process (GO:0006699) | 4.70784730 |
| 24 | regulation of protein activation cascade (GO:2000257) | 4.64401374 |
| 25 | kynurenine metabolic process (GO:0070189) | 4.52541144 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.51803373 |
| 27 | cysteine metabolic process (GO:0006534) | 4.51141762 |
| 28 | negative regulation of fibrinolysis (GO:0051918) | 4.50754376 |
| 29 | indole-containing compound catabolic process (GO:0042436) | 4.49292882 |
| 30 | indolalkylamine catabolic process (GO:0046218) | 4.49292882 |
| 31 | tryptophan catabolic process (GO:0006569) | 4.49292882 |
| 32 | urea cycle (GO:0000050) | 4.44231097 |
| 33 | urea metabolic process (GO:0019627) | 4.44231097 |
| 34 | high-density lipoprotein particle remodeling (GO:0034375) | 4.39619829 |
| 35 | regulation of complement activation (GO:0030449) | 4.37979152 |
| 36 | detection of bacterium (GO:0016045) | 4.35528286 |
| 37 | tryptophan metabolic process (GO:0006568) | 4.31006860 |
| 38 | aldehyde catabolic process (GO:0046185) | 4.30233096 |
| 39 | glyoxylate metabolic process (GO:0046487) | 4.29125468 |
| 40 | low-density lipoprotein particle clearance (GO:0034383) | 4.27727330 |
| 41 | positive regulation of mast cell activation (GO:0033005) | 4.24768027 |
| 42 | leukocyte aggregation (GO:0070486) | 4.23070378 |
| 43 | regulation of gamma-delta T cell activation (GO:0046643) | 4.22843908 |
| 44 | regulation of fibrinolysis (GO:0051917) | 4.21133234 |
| 45 | sulfur amino acid catabolic process (GO:0000098) | 4.20592917 |
| 46 | regulation of triglyceride catabolic process (GO:0010896) | 4.20492558 |
| 47 | microglial cell activation (GO:0001774) | 4.19934541 |
| 48 | detection of external biotic stimulus (GO:0098581) | 4.18548781 |
| 49 | macrophage activation (GO:0042116) | 4.17611028 |
| 50 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.15902945 |
| 51 | neutrophil mediated immunity (GO:0002446) | 4.08041581 |
| 52 | detection of biotic stimulus (GO:0009595) | 4.05697345 |
| 53 | nitrogen cycle metabolic process (GO:0071941) | 4.03869903 |
| 54 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.02506472 |
| 55 | bile acid metabolic process (GO:0008206) | 4.01219791 |
| 56 | modulation by symbiont of host defense response (GO:0052031) | 3.97088531 |
| 57 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.97088531 |
| 58 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.97088531 |
| 59 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.97088531 |
| 60 | modulation by symbiont of host immune response (GO:0052553) | 3.97088531 |
| 61 | positive regulation by symbiont of host defense response (GO:0052509) | 3.97088531 |
| 62 | respiratory burst (GO:0045730) | 3.96261866 |
| 63 | immunoglobulin mediated immune response (GO:0016064) | 3.89758371 |
| 64 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.88833708 |
| 65 | response to host immune response (GO:0052572) | 3.88833708 |
| 66 | neutrophil activation (GO:0042119) | 3.87549695 |
| 67 | reverse cholesterol transport (GO:0043691) | 3.86862985 |
| 68 | cofactor catabolic process (GO:0051187) | 3.83415014 |
| 69 | regulation of mast cell degranulation (GO:0043304) | 3.82044386 |
| 70 | plasma lipoprotein particle remodeling (GO:0034369) | 3.81749051 |
| 71 | protein-lipid complex remodeling (GO:0034368) | 3.81749051 |
| 72 | macromolecular complex remodeling (GO:0034367) | 3.81749051 |
| 73 | granulocyte activation (GO:0036230) | 3.76346013 |
| 74 | regulation of mast cell activation (GO:0033003) | 3.75991284 |
| 75 | response to muramyl dipeptide (GO:0032495) | 3.74665928 |
| 76 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.73741725 |
| 77 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.73028796 |
| 78 | negative regulation of T cell mediated immunity (GO:0002710) | 3.72209111 |
| 79 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.70039769 |
| 80 | myeloid cell activation involved in immune response (GO:0002275) | 3.69165492 |
| 81 | regulation of cholesterol esterification (GO:0010872) | 3.67981689 |
| 82 | amino-acid betaine metabolic process (GO:0006577) | 3.67543457 |
| 83 | negative regulation of sterol transport (GO:0032372) | 3.65090535 |
| 84 | negative regulation of cholesterol transport (GO:0032375) | 3.65090535 |
| 85 | phospholipid efflux (GO:0033700) | 3.65088746 |
| 86 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.64492257 |
| 87 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.63604427 |
| 88 | cholesterol efflux (GO:0033344) | 3.63497915 |
| 89 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.61266950 |
| 90 | tyrosine metabolic process (GO:0006570) | 3.60652292 |
| 91 | aromatic amino acid family metabolic process (GO:0009072) | 3.59701344 |
| 92 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.56943656 |
| 93 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.56020180 |
| 94 | response to host (GO:0075136) | 3.55996841 |
| 95 | response to host defenses (GO:0052200) | 3.55996841 |
| 96 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.55996841 |
| 97 | fibrinolysis (GO:0042730) | 3.55894259 |
| 98 | complement activation, classical pathway (GO:0006958) | 3.54828730 |
| 99 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.54492447 |
| 100 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.54211263 |
| 101 | positive regulation of mast cell degranulation (GO:0043306) | 3.54211263 |
| 102 | triglyceride homeostasis (GO:0070328) | 3.52566651 |
| 103 | acylglycerol homeostasis (GO:0055090) | 3.52566651 |
| 104 | complement activation (GO:0006956) | 3.51500692 |
| 105 | serine family amino acid catabolic process (GO:0009071) | 3.51170096 |
| 106 | regulation of tolerance induction (GO:0002643) | 3.49420712 |
| 107 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.49416257 |
| 108 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.45595073 |
| 109 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.44424285 |
| 110 | regulation of cholesterol storage (GO:0010885) | 3.43513694 |
| 111 | positive regulation of lipid catabolic process (GO:0050996) | 3.43375225 |
| 112 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.43347373 |
| 113 | regulation of T cell tolerance induction (GO:0002664) | 3.42877945 |
| 114 | myeloid leukocyte mediated immunity (GO:0002444) | 3.41981135 |
| 115 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.41690673 |
| 116 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.41690673 |
| 117 | bile acid and bile salt transport (GO:0015721) | 3.40970158 |
| 118 | defense response to protozoan (GO:0042832) | 3.40599316 |
| 119 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.39817320 |
| 120 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.39634747 |
| 121 | homocysteine metabolic process (GO:0050667) | 3.39300063 |
| 122 | lysine metabolic process (GO:0006553) | 3.35871722 |
| 123 | lysine catabolic process (GO:0006554) | 3.35871722 |
| 124 | protein activation cascade (GO:0072376) | 3.33959301 |
| 125 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.33472720 |
| 126 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.33472720 |
| 127 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.33000761 |
| 128 | regulation of cholesterol homeostasis (GO:2000188) | 3.32124925 |
| 129 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.31171082 |
| 130 | imidazole-containing compound metabolic process (GO:0052803) | 3.29917737 |
| 131 | positive regulation of type 2 immune response (GO:0002830) | 3.29453767 |
| 132 | plasma lipoprotein particle assembly (GO:0034377) | 3.29436882 |
| 133 | alpha-amino acid catabolic process (GO:1901606) | 3.28579314 |
| 134 | regulation of leukocyte degranulation (GO:0043300) | 3.24451512 |
| 135 | cellular ketone body metabolic process (GO:0046950) | 3.23424126 |
| 136 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.21557467 |
| 137 | response to protozoan (GO:0001562) | 3.20901340 |
| 138 | primary alcohol catabolic process (GO:0034310) | 3.20551115 |
| 139 | glutamate metabolic process (GO:0006536) | 3.19998767 |
| 140 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.19871646 |
| 141 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.19483687 |
| 142 | neutrophil chemotaxis (GO:0030593) | 3.17857415 |
| 143 | cellular modified amino acid catabolic process (GO:0042219) | 3.17248783 |
| 144 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.17037666 |
| 145 | acute-phase response (GO:0006953) | 3.16596744 |
| 146 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.16259119 |
| 147 | ethanol oxidation (GO:0006069) | 3.15435106 |
| 148 | cellular glucuronidation (GO:0052695) | 3.14872422 |
| 149 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.14124408 |
| 150 | arginine metabolic process (GO:0006525) | 3.12260063 |
| 151 | lipoprotein metabolic process (GO:0042157) | 3.11167526 |
| 152 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.11095384 |
| 153 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.10996316 |
| 154 | indolalkylamine metabolic process (GO:0006586) | 3.10858180 |
| 155 | low-density lipoprotein particle remodeling (GO:0034374) | 3.10069541 |
| 156 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.10052128 |
| 157 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.09933588 |
| 158 | neutrophil migration (GO:1990266) | 3.09675179 |
| 159 | cholesterol homeostasis (GO:0042632) | 3.09529439 |
| 160 | lipoprotein transport (GO:0042953) | 3.08502195 |
| 161 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.08479183 |
| 162 | protein-lipid complex assembly (GO:0065005) | 3.08126013 |
| 163 | glycine metabolic process (GO:0006544) | 3.08015254 |
| 164 | negative regulation of interleukin-1 production (GO:0032692) | 3.06647515 |
| 165 | regulation of antigen processing and presentation (GO:0002577) | 3.06350593 |
| 166 | uronic acid metabolic process (GO:0006063) | 3.05950693 |
| 167 | glucuronate metabolic process (GO:0019585) | 3.05950693 |
| 168 | sterol homeostasis (GO:0055092) | 3.04137582 |
| 169 | regulation of interleukin-17 production (GO:0032660) | 3.04023887 |
| 170 | cellular amino acid catabolic process (GO:0009063) | 3.03279167 |
| 171 | negative regulation of interleukin-17 production (GO:0032700) | 3.01975614 |
| 172 | germinal center formation (GO:0002467) | 3.01857484 |
| 173 | heme transport (GO:0015886) | 3.01369756 |
| 174 | plasma lipoprotein particle organization (GO:0071827) | 3.00957854 |
| 175 | interferon-gamma production (GO:0032609) | 2.99776666 |
| 176 | T-helper 1 type immune response (GO:0042088) | 2.98965928 |
| 177 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.98795264 |
| 178 | myeloid leukocyte activation (GO:0002274) | 2.98425493 |
| 179 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.97173436 |
| 180 | positive regulation of tolerance induction (GO:0002645) | 2.96631753 |
| 181 | positive regulation of antigen processing and presentation (GO:0002579) | 2.96293082 |
| 182 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.94737682 |
| 183 | B cell mediated immunity (GO:0019724) | 2.94474271 |
| 184 | cytokine secretion (GO:0050663) | 2.92613383 |
| 185 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.92126386 |
| 186 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.91943959 |
| 187 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.90693938 |
| 188 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.88009251 |
| 189 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.86922565 |
| 190 | T cell migration (GO:0072678) | 2.86085872 |
| 191 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.85779713 |
| 192 | regulation of macrophage cytokine production (GO:0010935) | 2.85767046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.91586524 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.28217993 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.47043497 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.98289031 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.89469474 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.95827142 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.84021781 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.80351748 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.71620539 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.59052710 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.01502474 |
| 12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.89410380 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.84058750 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.74740111 |
| 15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65615631 |
| 16 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48392869 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.39206029 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.28715519 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.19408148 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.18596119 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.06259688 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.03767296 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.03010997 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.86448554 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.85645653 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.84639188 |
| 27 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81431099 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.77399505 |
| 29 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77189723 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.75529196 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.69719991 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.69447840 |
| 33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.67207662 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.63549231 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59769594 |
| 36 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.59147974 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.58560187 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54188322 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51754873 |
| 40 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48903256 |
| 41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.41589129 |
| 42 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36006308 |
| 43 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34231893 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.31717906 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31665758 |
| 46 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.31495399 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.29757992 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.28638854 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.27748201 |
| 50 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.26146667 |
| 51 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25701688 |
| 52 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.25256960 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24483446 |
| 54 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21736594 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21732001 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19872226 |
| 57 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.18794695 |
| 58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.18725310 |
| 59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16004666 |
| 60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14011710 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11775237 |
| 62 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.11710146 |
| 63 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.11610113 |
| 64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11572391 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11440160 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11402913 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09408013 |
| 68 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07785744 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07201710 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06294624 |
| 71 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05326237 |
| 72 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03188025 |
| 73 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.02007843 |
| 74 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01741433 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01017964 |
| 76 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.98021963 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96981894 |
| 78 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96657176 |
| 79 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95068621 |
| 80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94736338 |
| 81 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.94561593 |
| 82 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94456663 |
| 83 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93454861 |
| 84 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.93071511 |
| 85 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92417243 |
| 86 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.91693465 |
| 87 | MAF_26560356_Chip-Seq_TH1_Human | 0.91417978 |
| 88 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90452523 |
| 89 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90066444 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90047477 |
| 91 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.89888374 |
| 92 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88952700 |
| 93 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88450854 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87447913 |
| 95 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.86619593 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85737877 |
| 97 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85046887 |
| 98 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82783605 |
| 99 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82398258 |
| 100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81686022 |
| 101 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 0.80005306 |
| 102 | MYB_26560356_Chip-Seq_TH1_Human | 0.79771160 |
| 103 | MYB_26560356_Chip-Seq_TH2_Human | 0.79263476 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78379076 |
| 105 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77758197 |
| 106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.77684375 |
| 107 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.77525753 |
| 108 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.77237900 |
| 109 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77229286 |
| 110 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.76071178 |
| 111 | UTX_26944678_Chip-Seq_JUKART_Human | 0.75730188 |
| 112 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74716174 |
| 113 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.74293866 |
| 114 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73840664 |
| 115 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.73516888 |
| 116 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.73303465 |
| 117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72812745 |
| 118 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.72424605 |
| 119 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72375139 |
| 120 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.71821061 |
| 121 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.71644547 |
| 122 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71608473 |
| 123 | MYC_22102868_ChIP-Seq_BL_Human | 0.70961583 |
| 124 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.70654553 |
| 125 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.69784388 |
| 126 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.69470617 |
| 127 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.68829146 |
| 128 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68462835 |
| 129 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.67320973 |
| 130 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.66184492 |
| 131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65920501 |
| 132 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65920501 |
| 133 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.65834785 |
| 134 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.65293952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.89528553 |
| 2 | MP0005360_urolithiasis | 5.59519448 |
| 3 | MP0005365_abnormal_bile_salt | 4.47755321 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.40785447 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.72903213 |
| 6 | MP0009840_abnormal_foam_cell | 3.66481773 |
| 7 | MP0005083_abnormal_biliary_tract | 3.59349840 |
| 8 | MP0003195_calcinosis | 3.34614513 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.98347006 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.90273079 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.77497106 |
| 12 | MP0003252_abnormal_bile_duct | 2.70292625 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.59961423 |
| 14 | MP0003436_decreased_susceptibility_to | 2.53671910 |
| 15 | MP0003303_peritoneal_inflammation | 2.49592830 |
| 16 | MP0000604_amyloidosis | 2.19456860 |
| 17 | MP0003828_pulmonary_edema | 2.18296600 |
| 18 | MP0005332_abnormal_amino_acid | 1.99888473 |
| 19 | MP0001835_abnormal_antigen_presentation | 1.98120197 |
| 20 | MP0000609_abnormal_liver_physiology | 1.92358579 |
| 21 | MP0003656_abnormal_erythrocyte_physiolo | 1.86465336 |
| 22 | MP0002419_abnormal_innate_immunity | 1.81126172 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.79418115 |
| 24 | MP0010155_abnormal_intestine_physiology | 1.72053296 |
| 25 | MP0008260_abnormal_autophagy | 1.71030109 |
| 26 | MP0006082_CNS_inflammation | 1.68981425 |
| 27 | MP0009785_altered_susceptibility_to | 1.68463585 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.67780741 |
| 29 | MP0002998_abnormal_bone_remodeling | 1.67582232 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.63040705 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.63015915 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.61667446 |
| 33 | MP0009764_decreased_sensitivity_to | 1.55928520 |
| 34 | MP0008469_abnormal_protein_level | 1.54689294 |
| 35 | MP0000858_altered_metastatic_potential | 1.48835227 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.48173416 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.46396571 |
| 38 | MP0002398_abnormal_bone_marrow | 1.46095660 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.43270770 |
| 40 | MP0005025_abnormal_response_to | 1.42903948 |
| 41 | MP0005310_abnormal_salivary_gland | 1.42188411 |
| 42 | MP0003186_abnormal_redox_activity | 1.40503836 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.40342056 |
| 44 | MP0005387_immune_system_phenotype | 1.38718387 |
| 45 | MP0001790_abnormal_immune_system | 1.38718387 |
| 46 | MP0008004_abnormal_stomach_pH | 1.37594664 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.37437348 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.34146441 |
| 49 | MP0001800_abnormal_humoral_immune | 1.34071998 |
| 50 | MP0009763_increased_sensitivity_to | 1.33161545 |
| 51 | MP0003763_abnormal_thymus_physiology | 1.30325852 |
| 52 | MP0003724_increased_susceptibility_to | 1.30243266 |
| 53 | MP0005451_abnormal_body_composition | 1.29814022 |
| 54 | MP0003690_abnormal_glial_cell | 1.29630651 |
| 55 | MP0002132_abnormal_respiratory_system | 1.28842240 |
| 56 | MP0004019_abnormal_vitamin_homeostasis | 1.23966748 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.23701846 |
| 58 | MP0001764_abnormal_homeostasis | 1.22758322 |
| 59 | MP0004947_skin_inflammation | 1.22386067 |
| 60 | MP0009643_abnormal_urine_homeostasis | 1.22180307 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.22172629 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.21381866 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.21009506 |
| 64 | MP0002452_abnormal_antigen_presenting | 1.18468891 |
| 65 | MP0000598_abnormal_liver_morphology | 1.18401408 |
| 66 | MP0003075_altered_response_to | 1.16376335 |
| 67 | MP0004510_myositis | 1.15595101 |
| 68 | MP0006054_spinal_hemorrhage | 1.11972829 |
| 69 | MP0002723_abnormal_immune_serum | 1.10977473 |
| 70 | MP0000685_abnormal_immune_system | 1.06264265 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 1.02211244 |
| 72 | MP0001851_eye_inflammation | 1.00324909 |
| 73 | MP0005166_decreased_susceptibility_to | 1.00310079 |
| 74 | MP0009278_abnormal_bone_marrow | 0.97862749 |
| 75 | MP0003868_abnormal_feces_composition | 0.94507554 |
| 76 | MP0000343_altered_response_to | 0.93614368 |
| 77 | MP0001545_abnormal_hematopoietic_system | 0.93404706 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 0.93404706 |
| 79 | MP0005390_skeleton_phenotype | 0.92864198 |
| 80 | MP0002166_altered_tumor_susceptibility | 0.92023892 |
| 81 | MP0003866_abnormal_defecation | 0.90568173 |
| 82 | MP0002148_abnormal_hypersensitivity_rea | 0.90253535 |
| 83 | MP0001819_abnormal_immune_cell | 0.90159365 |
| 84 | MP0002420_abnormal_adaptive_immunity | 0.89867816 |
| 85 | MP0002332_abnormal_exercise_endurance | 0.87569290 |
| 86 | MP0001663_abnormal_digestive_system | 0.86519017 |
| 87 | MP0000689_abnormal_spleen_morphology | 0.85736847 |
| 88 | MP0003011_delayed_dark_adaptation | 0.85287476 |
| 89 | MP0001853_heart_inflammation | 0.84399381 |
| 90 | MP0000703_abnormal_thymus_morphology | 0.83749409 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.81554356 |
| 92 | MP0009642_abnormal_blood_homeostasis | 0.79692506 |
| 93 | MP0000920_abnormal_myelination | 0.79345137 |
| 94 | MP0003329_amyloid_beta_deposits | 0.78346898 |
| 95 | MP0009697_abnormal_copulation | 0.77484998 |
| 96 | MP0002254_reproductive_system_inflammat | 0.76345001 |
| 97 | MP0005671_abnormal_response_to | 0.74475798 |
| 98 | MP0002405_respiratory_system_inflammati | 0.74087127 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.73477204 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.73299560 |
| 101 | MP0003566_abnormal_cell_adhesion | 0.73294649 |
| 102 | MP0003795_abnormal_bone_structure | 0.72076586 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.71546703 |
| 104 | MP0005376_homeostasis/metabolism_phenot | 0.71106013 |
| 105 | MP0008873_increased_physiological_sensi | 0.70243589 |
| 106 | MP0002090_abnormal_vision | 0.69800567 |
| 107 | MP0005636_abnormal_mineral_homeostasis | 0.69534265 |
| 108 | MP0004782_abnormal_surfactant_physiolog | 0.69290433 |
| 109 | MP0004883_abnormal_blood_vessel | 0.68959215 |
| 110 | MP0005023_abnormal_wound_healing | 0.68446109 |
| 111 | MP0000716_abnormal_immune_system | 0.68200883 |
| 112 | MP0005164_abnormal_response_to | 0.67434350 |
| 113 | MP0000249_abnormal_blood_vessel | 0.66439512 |
| 114 | MP0003448_altered_tumor_morphology | 0.66366552 |
| 115 | MP0000569_abnormal_digit_pigmentation | 0.64781188 |
| 116 | MP0008874_decreased_physiological_sensi | 0.63973772 |
| 117 | MP0010307_abnormal_tumor_latency | 0.63789272 |
| 118 | MP0002933_joint_inflammation | 0.63511252 |
| 119 | MP0004130_abnormal_muscle_cell | 0.63121654 |
| 120 | MP0004808_abnormal_hematopoietic_stem | 0.61815144 |
| 121 | MP0003091_abnormal_cell_migration | 0.61483146 |
| 122 | MP0002971_abnormal_brown_adipose | 0.61305489 |
| 123 | MP0002006_tumorigenesis | 0.60906926 |
| 124 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60584369 |
| 125 | MP0001756_abnormal_urination | 0.60034577 |
| 126 | MP0001873_stomach_inflammation | 0.59757297 |
| 127 | MP0005334_abnormal_fat_pad | 0.58869676 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.58474062 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.57862646 |
| 130 | MP0004381_abnormal_hair_follicle | 0.57479905 |
| 131 | MP0003045_fibrosis | 0.56962006 |
| 132 | MP0002722_abnormal_immune_system | 0.56315779 |
| 133 | MP0002429_abnormal_blood_cell | 0.56214647 |
| 134 | MP0004484_altered_response_of | 0.54517612 |
| 135 | MP0000371_diluted_coat_color | 0.54285380 |
| 136 | MP0002009_preneoplasia | 0.51101665 |
| 137 | MP0005535_abnormal_body_temperature | 0.50724539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 5.95340534 |
| 2 | Orchitis (HP:0100796) | 5.94770293 |
| 3 | Optic neuritis (HP:0100653) | 5.94748922 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 5.94748922 |
| 5 | Deep venous thrombosis (HP:0002625) | 5.79432297 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.75754580 |
| 7 | Stomatitis (HP:0010280) | 5.65127000 |
| 8 | Complement deficiency (HP:0004431) | 5.57475233 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 5.32167147 |
| 10 | Xanthomatosis (HP:0000991) | 5.26271477 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.21877633 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.13814970 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.99713261 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.75280610 |
| 15 | Prolonged partial thromboplastin time (HP:0003645) | 4.52565104 |
| 16 | Abnormality of complement system (HP:0005339) | 4.50201223 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 4.47194181 |
| 18 | Hypobetalipoproteinemia (HP:0003563) | 4.42469851 |
| 19 | Vacuolated lymphocytes (HP:0001922) | 4.16768005 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 4.14667455 |
| 21 | Joint hemorrhage (HP:0005261) | 4.12825939 |
| 22 | Glomerulonephritis (HP:0000099) | 4.04086550 |
| 23 | Recurrent fungal infections (HP:0002841) | 3.96325794 |
| 24 | Keratoconjunctivitis (HP:0001096) | 3.84367014 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.64225461 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.62212731 |
| 27 | Epidermoid cyst (HP:0200040) | 3.60685368 |
| 28 | Obstructive lung disease (HP:0006536) | 3.60263352 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 3.60263352 |
| 30 | Eczematoid dermatitis (HP:0000976) | 3.58393172 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.58132400 |
| 32 | Vasculitis (HP:0002633) | 3.54984024 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 3.47685721 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.47685721 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.47685721 |
| 36 | Meningitis (HP:0001287) | 3.46050599 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.45824676 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 3.45824676 |
| 39 | Hypolipoproteinemia (HP:0010981) | 3.45761811 |
| 40 | Episodic fever (HP:0001954) | 3.45593801 |
| 41 | Hemoptysis (HP:0002105) | 3.41957799 |
| 42 | Myocardial infarction (HP:0001658) | 3.39951901 |
| 43 | Encephalitis (HP:0002383) | 3.37907524 |
| 44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.35258550 |
| 45 | Pulmonary infiltrates (HP:0002113) | 3.30503410 |
| 46 | Recurrent abscess formation (HP:0002722) | 3.30328887 |
| 47 | Increased cerebral lipofuscin (HP:0011813) | 3.28511458 |
| 48 | Recurrent bacterial skin infections (HP:0005406) | 3.26273245 |
| 49 | Dysostosis multiplex (HP:0000943) | 3.21937733 |
| 50 | Hyperammonemia (HP:0001987) | 3.20704059 |
| 51 | Hypoalphalipoproteinemia (HP:0003233) | 3.20196119 |
| 52 | Arterial thrombosis (HP:0004420) | 3.18177234 |
| 53 | Fat malabsorption (HP:0002630) | 3.18150080 |
| 54 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.07934557 |
| 55 | Leukocytosis (HP:0001974) | 3.05719689 |
| 56 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.04115953 |
| 57 | Recurrent viral infections (HP:0004429) | 3.03391384 |
| 58 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.01989698 |
| 59 | Ketosis (HP:0001946) | 2.98330577 |
| 60 | Gangrene (HP:0100758) | 2.93861411 |
| 61 | Abnormality of the intrinsic pathway (HP:0010989) | 2.90655320 |
| 62 | Esophageal varix (HP:0002040) | 2.88001026 |
| 63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.86590730 |
| 64 | Axonal loss (HP:0003447) | 2.83127695 |
| 65 | Amyloidosis (HP:0011034) | 2.77190452 |
| 66 | Hematochezia (HP:0002573) | 2.76986925 |
| 67 | Loss of speech (HP:0002371) | 2.75613517 |
| 68 | Chest pain (HP:0100749) | 2.73915743 |
| 69 | Hyperglycinemia (HP:0002154) | 2.73854689 |
| 70 | Abnormality of methionine metabolism (HP:0010901) | 2.72472062 |
| 71 | Prolonged bleeding time (HP:0003010) | 2.70940090 |
| 72 | Hypoglycemic coma (HP:0001325) | 2.67352905 |
| 73 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.67035268 |
| 74 | Abnormality of macrophages (HP:0004311) | 2.65479169 |
| 75 | Anorexia (HP:0002039) | 2.64684190 |
| 76 | Increased IgE level (HP:0003212) | 2.64124146 |
| 77 | Abnormality of the lumbar spine (HP:0100712) | 2.63603137 |
| 78 | Skin nodule (HP:0200036) | 2.62449709 |
| 79 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.62045715 |
| 80 | Nephritis (HP:0000123) | 2.60179195 |
| 81 | Mucopolysacchariduria (HP:0008155) | 2.58183341 |
| 82 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.58183341 |
| 83 | T lymphocytopenia (HP:0005403) | 2.56834384 |
| 84 | Steatorrhea (HP:0002570) | 2.55843865 |
| 85 | Conjunctival telangiectasia (HP:0000524) | 2.54124448 |
| 86 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.53998551 |
| 87 | Hepatocellular carcinoma (HP:0001402) | 2.53622515 |
| 88 | Cellulitis (HP:0100658) | 2.52188283 |
| 89 | Spastic diplegia (HP:0001264) | 2.51841870 |
| 90 | Thoracic kyphosis (HP:0002942) | 2.50067832 |
| 91 | Hypochromic microcytic anemia (HP:0004840) | 2.49562781 |
| 92 | Polyneuropathy (HP:0001271) | 2.48895250 |
| 93 | Gingival bleeding (HP:0000225) | 2.48004846 |
| 94 | Abnormality of T cell number (HP:0011839) | 2.47226474 |
| 95 | Vertigo (HP:0002321) | 2.45991096 |
| 96 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.43962803 |
| 97 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.43962803 |
| 98 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.43962803 |
| 99 | Abnormality of nucleobase metabolism (HP:0010932) | 2.43778687 |
| 100 | Petechiae (HP:0000967) | 2.41960854 |
| 101 | Upper motor neuron abnormality (HP:0002127) | 2.40149075 |
| 102 | Epistaxis (HP:0000421) | 2.39794460 |
| 103 | Abnormality of purine metabolism (HP:0004352) | 2.38668754 |
| 104 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.36861576 |
| 105 | Abnormality of glycine metabolism (HP:0010895) | 2.36861576 |
| 106 | Abnormality of the pleura (HP:0002103) | 2.34429981 |
| 107 | Disinhibition (HP:0000734) | 2.32730990 |
| 108 | Spontaneous abortion (HP:0005268) | 2.31302097 |
| 109 | Urticaria (HP:0001025) | 2.31168356 |
| 110 | Increased IgM level (HP:0003496) | 2.30685394 |
| 111 | Conjugated hyperbilirubinemia (HP:0002908) | 2.29860102 |
| 112 | Hyperglycinuria (HP:0003108) | 2.29775459 |
| 113 | Hyperbilirubinemia (HP:0002904) | 2.29760151 |
| 114 | Mitral stenosis (HP:0001718) | 2.28887616 |
| 115 | Malnutrition (HP:0004395) | 2.28733610 |
| 116 | Osteomyelitis (HP:0002754) | 2.25482227 |
| 117 | Recurrent skin infections (HP:0001581) | 2.23252850 |
| 118 | Inflammation of the large intestine (HP:0002037) | 2.22620756 |
| 119 | Purpura (HP:0000979) | 2.22552557 |
| 120 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.21030954 |
| 121 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.20400408 |
| 122 | Sensorimotor neuropathy (HP:0007141) | 2.20388348 |
| 123 | Thrombophlebitis (HP:0004418) | 2.20364057 |
| 124 | Pustule (HP:0200039) | 2.20240632 |
| 125 | Abnormality of the endocardium (HP:0004306) | 2.20043315 |
| 126 | Spontaneous hematomas (HP:0007420) | 2.19744216 |
| 127 | Polycythemia (HP:0001901) | 2.18911128 |
| 128 | Abnormality of iron homeostasis (HP:0011031) | 2.14256611 |
| 129 | Glomerulopathy (HP:0100820) | 2.13902674 |
| 130 | Pulmonary embolism (HP:0002204) | 2.13366885 |
| 131 | Colitis (HP:0002583) | 2.12352650 |
| 132 | Cholelithiasis (HP:0001081) | 2.10791032 |
| 133 | Abnormal gallbladder morphology (HP:0012437) | 2.09850396 |
| 134 | Acne (HP:0001061) | 2.09726568 |
| 135 | Abnormality of T cells (HP:0002843) | 2.09142580 |
| 136 | Gastrointestinal inflammation (HP:0004386) | 2.08444047 |
| 137 | Gingivitis (HP:0000230) | 2.08378976 |
| 138 | Keratitis (HP:0000491) | 2.08377353 |
| 139 | Amaurosis fugax (HP:0100576) | 2.04167516 |
| 140 | Sepsis (HP:0100806) | 2.04112366 |
| 141 | Ketoacidosis (HP:0001993) | 2.02556510 |
| 142 | Autoimmune thrombocytopenia (HP:0001973) | 1.99699449 |
| 143 | Mutism (HP:0002300) | 1.96651323 |
| 144 | Menorrhagia (HP:0000132) | 1.96600219 |
| 145 | Granulocytopenia (HP:0001913) | 1.96015750 |
| 146 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94856567 |
| 147 | Autoimmune hemolytic anemia (HP:0001890) | 1.94480837 |
| 148 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93688314 |
| 149 | Neuronal loss in central nervous system (HP:0002529) | 1.93514505 |
| 150 | Memory impairment (HP:0002354) | 1.92115252 |
| 151 | Increased serum ferritin (HP:0003281) | 1.90960876 |
| 152 | Cheilitis (HP:0100825) | 1.90764974 |
| 153 | Abnormality of the pericardium (HP:0001697) | 1.90506389 |
| 154 | Arthralgia (HP:0002829) | 1.89193750 |
| 155 | Irritability (HP:0000737) | 1.88990081 |
| 156 | Peripheral demyelination (HP:0011096) | 1.86959622 |
| 157 | Periodontitis (HP:0000704) | 1.86377445 |
| 158 | Premature loss of primary teeth (HP:0006323) | 1.86149544 |
| 159 | Hypergammaglobulinemia (HP:0010702) | 1.86031868 |
| 160 | Abnormal gallbladder physiology (HP:0012438) | 1.85687632 |
| 161 | Cholecystitis (HP:0001082) | 1.85687632 |
| 162 | Eosinophilia (HP:0001880) | 1.84966841 |
| 163 | Mediastinal lymphadenopathy (HP:0100721) | 1.83668035 |
| 164 | Abnormality of the peritoneum (HP:0002585) | 1.82732710 |
| 165 | Global brain atrophy (HP:0002283) | 1.82072691 |
| 166 | Abnormality of the gallbladder (HP:0005264) | 1.81028466 |
| 167 | Fatigue (HP:0012378) | 1.80345278 |
| 168 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.79283196 |
| 169 | Hemorrhage of the eye (HP:0011885) | 1.79243233 |
| 170 | Acanthocytosis (HP:0001927) | 1.77564441 |
| 171 | Peritonitis (HP:0002586) | 1.77412926 |
| 172 | Vascular calcification (HP:0004934) | 1.77340147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.54495123 |
| 2 | TYK2 | 3.26639325 |
| 3 | TBK1 | 2.90115885 |
| 4 | NME2 | 2.75687556 |
| 5 | PRPF4B | 2.71827978 |
| 6 | FGFR4 | 2.70755085 |
| 7 | STK10 | 2.70162843 |
| 8 | CSF1R | 2.66722292 |
| 9 | BCKDK | 2.46358824 |
| 10 | TGFBR2 | 2.37095293 |
| 11 | PKN2 | 2.23934582 |
| 12 | FES | 2.14681413 |
| 13 | MAP4K1 | 2.13069739 |
| 14 | BLK | 2.07951264 |
| 15 | TAOK3 | 2.03950462 |
| 16 | IRAK4 | 1.95054535 |
| 17 | KIT | 1.94366060 |
| 18 | RIPK4 | 1.92392308 |
| 19 | CSK | 1.87859865 |
| 20 | STK24 | 1.84431862 |
| 21 | FGR | 1.83294191 |
| 22 | BMPR2 | 1.79363990 |
| 23 | MAP3K13 | 1.66885006 |
| 24 | TRIB3 | 1.65458572 |
| 25 | PIK3CG | 1.61265516 |
| 26 | JAK1 | 1.59256982 |
| 27 | RPS6KA4 | 1.54578648 |
| 28 | MAP3K14 | 1.54573197 |
| 29 | TNK2 | 1.52871863 |
| 30 | TAOK1 | 1.47237397 |
| 31 | LRRK2 | 1.46917015 |
| 32 | JAK2 | 1.45783839 |
| 33 | SIK1 | 1.42334455 |
| 34 | ERBB4 | 1.41926115 |
| 35 | CAMK1D | 1.41626980 |
| 36 | MAP2K3 | 1.35139984 |
| 37 | IKBKE | 1.35122337 |
| 38 | EPHB1 | 1.33770320 |
| 39 | JAK3 | 1.33138847 |
| 40 | KSR2 | 1.32315819 |
| 41 | IRAK3 | 1.31753567 |
| 42 | IRAK2 | 1.31364323 |
| 43 | FLT3 | 1.28581349 |
| 44 | IRAK1 | 1.25998673 |
| 45 | TTN | 1.23251629 |
| 46 | DAPK2 | 1.19172811 |
| 47 | DYRK1B | 1.18890131 |
| 48 | GRK6 | 1.15197536 |
| 49 | KDR | 1.09631275 |
| 50 | SYK | 1.08582440 |
| 51 | SIK3 | 1.08463585 |
| 52 | HCK | 1.08213067 |
| 53 | MATK | 1.07128719 |
| 54 | ZAP70 | 1.06536887 |
| 55 | PTK6 | 1.05284907 |
| 56 | RIPK1 | 1.04767012 |
| 57 | PBK | 1.03568556 |
| 58 | MAPK11 | 1.01801837 |
| 59 | LYN | 1.01124105 |
| 60 | NEK9 | 1.00185687 |
| 61 | CDK6 | 0.99458112 |
| 62 | MAP3K3 | 0.98799648 |
| 63 | EGFR | 0.91587562 |
| 64 | CDC42BPA | 0.88447279 |
| 65 | CAMK1G | 0.87781853 |
| 66 | MAPK7 | 0.84350023 |
| 67 | LCK | 0.83753213 |
| 68 | IKBKB | 0.82648263 |
| 69 | ABL2 | 0.78352076 |
| 70 | TAOK2 | 0.78187740 |
| 71 | TEC | 0.77936832 |
| 72 | DDR2 | 0.77537503 |
| 73 | YES1 | 0.76787212 |
| 74 | MOS | 0.76213706 |
| 75 | MAP3K8 | 0.75215433 |
| 76 | MAPK4 | 0.74692752 |
| 77 | MARK2 | 0.67765130 |
| 78 | GRK7 | 0.64002986 |
| 79 | NEK1 | 0.62891501 |
| 80 | PRKCD | 0.61025234 |
| 81 | PRKCQ | 0.60541086 |
| 82 | CDK4 | 0.59344122 |
| 83 | MAP3K5 | 0.58293288 |
| 84 | BTK | 0.57328258 |
| 85 | EPHA3 | 0.56595980 |
| 86 | MAP3K2 | 0.55721360 |
| 87 | CAMKK2 | 0.55350312 |
| 88 | PRKACG | 0.54766359 |
| 89 | MAP3K1 | 0.53598945 |
| 90 | PDK1 | 0.53392764 |
| 91 | IGF1R | 0.53070632 |
| 92 | KSR1 | 0.52695950 |
| 93 | MAP2K4 | 0.52673591 |
| 94 | MARK3 | 0.52182382 |
| 95 | FYN | 0.52175246 |
| 96 | ARAF | 0.51080960 |
| 97 | CHUK | 0.49241816 |
| 98 | PRKD2 | 0.48376055 |
| 99 | ABL1 | 0.48021678 |
| 100 | INSRR | 0.46449457 |
| 101 | SIK2 | 0.46391224 |
| 102 | ITK | 0.45300227 |
| 103 | GSK3A | 0.45217338 |
| 104 | TESK2 | 0.44870220 |
| 105 | PDPK1 | 0.44526652 |
| 106 | SGK3 | 0.44461163 |
| 107 | RPS6KL1 | 0.42934367 |
| 108 | RPS6KC1 | 0.42934367 |
| 109 | PIM1 | 0.42651369 |
| 110 | STK38L | 0.42628630 |
| 111 | PRKCH | 0.40667768 |
| 112 | MAP3K10 | 0.40001926 |
| 113 | CAMKK1 | 0.39469945 |
| 114 | FGFR3 | 0.39397606 |
| 115 | MST1R | 0.39100243 |
| 116 | CDC7 | 0.38349125 |
| 117 | RPS6KA6 | 0.37103251 |
| 118 | MAP3K6 | 0.36474322 |
| 119 | TYRO3 | 0.35980165 |
| 120 | TXK | 0.35885554 |
| 121 | SCYL2 | 0.34621850 |
| 122 | PDGFRB | 0.34493420 |
| 123 | MAP3K11 | 0.34483320 |
| 124 | MAP3K9 | 0.34366577 |
| 125 | MAPK12 | 0.34346741 |
| 126 | RAF1 | 0.31447359 |
| 127 | ADRBK2 | 0.30953011 |
| 128 | MAP2K1 | 0.29859068 |
| 129 | PDK2 | 0.29282368 |
| 130 | ACVR1B | 0.28939077 |
| 131 | MAP3K7 | 0.28523020 |
| 132 | DAPK3 | 0.28497888 |
| 133 | HIPK2 | 0.28124191 |
| 134 | SGK2 | 0.27639067 |
| 135 | STK11 | 0.25581950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.34137812 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.78303125 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.65033040 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.32490471 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24012740 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.08922622 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.90675993 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.67587032 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.49600199 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46616778 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.34012369 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.30976634 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.26492926 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.18617834 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.16306288 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.15888810 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.08193463 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.98792455 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.92452037 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91038302 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.89385777 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.87907550 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.84545714 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.79021018 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.76717440 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72788795 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.67509166 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66991688 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.63567026 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.62201919 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.61191270 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.60234102 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.57853244 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.55717739 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.55123068 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.54579760 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.50134678 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41886245 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.40689462 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.40258008 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35278471 |
| 42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.33202610 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.31471125 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.28512738 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27477103 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.27455447 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.25140129 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.25128639 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.23642971 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.22546181 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19099847 |
| 52 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.18926100 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18382972 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17565550 |
| 55 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17096508 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16888263 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.15341156 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 1.13135697 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10054442 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.07977026 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07795136 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 1.07572384 |
| 63 | Leishmaniasis_Homo sapiens_hsa05140 | 1.07073446 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06795195 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98950270 |
| 66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.94455014 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.93705098 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.90712034 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90289175 |
| 70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88861662 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.87168701 |
| 72 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86940300 |
| 73 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.86505518 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.85318987 |
| 75 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85046427 |
| 76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.83333609 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.82961009 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79898548 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 0.79696553 |
| 80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.78145589 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77332468 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77038174 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76375472 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75285805 |
| 85 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75281392 |
| 86 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.72026546 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71492165 |
| 88 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69434446 |
| 89 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68965692 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.68741901 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68682062 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68324723 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67406473 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66861720 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.64470266 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64341873 |
| 97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63214184 |
| 98 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62551679 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61915551 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61299476 |
| 101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60197228 |
| 102 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60060642 |
| 103 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59619308 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59560095 |
| 105 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59251425 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59125716 |
| 107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58832161 |
| 108 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58046454 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57432893 |
| 110 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57023474 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55966735 |
| 112 | Legionellosis_Homo sapiens_hsa05134 | 0.55854670 |
| 113 | Phagosome_Homo sapiens_hsa04145 | 0.55169834 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | 0.53612884 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53351858 |
| 116 | Malaria_Homo sapiens_hsa05144 | 0.52482042 |
| 117 | Tuberculosis_Homo sapiens_hsa05152 | 0.49411009 |
| 118 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47210950 |
| 119 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47195190 |
| 120 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46066984 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46013737 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.45930563 |
| 123 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.45704559 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45122678 |
| 125 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.44769867 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44740076 |
| 127 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44343562 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44309463 |
| 129 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43385944 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43357570 |
| 131 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.40156909 |
| 132 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36162041 |
| 133 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.35883615 |
| 134 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.35713186 |
| 135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34212941 |
| 136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33709854 |
| 137 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33603201 |
| 138 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32505757 |
| 139 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.31151912 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.31009356 |
| 141 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29047105 |
| 142 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28487129 |
| 143 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.28482928 |
| 144 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.27015774 |
| 145 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.26450839 |
| 146 | Hepatitis C_Homo sapiens_hsa05160 | 0.23853244 |
| 147 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.23320803 |
| 148 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.22816078 |
| 149 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22488240 |
| 150 | Measles_Homo sapiens_hsa05162 | 0.22241750 |
| 151 | Shigellosis_Homo sapiens_hsa05131 | 0.20985827 |
| 152 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.20286428 |
| 153 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.20082921 |
| 154 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.19897077 |
| 155 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.18891632 |
| 156 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.17347248 |
| 157 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.17138903 |
| 158 | Amoebiasis_Homo sapiens_hsa05146 | 0.16506615 |
| 159 | Influenza A_Homo sapiens_hsa05164 | 0.16420192 |
| 160 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.16178063 |
| 161 | Salmonella infection_Homo sapiens_hsa05132 | 0.16045390 |
| 162 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.15041838 |
| 163 | Metabolic pathways_Homo sapiens_hsa01100 | 0.13116177 |

